Integ. Thermopl. (530921)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 5/9 shows moderate financial health, not complete distress on all metrics.
• Profit growth of +61.89% indicates some recent improvement, albeit from a low or loss-making base.
• Reported ROE of 6.39% is positive, though inconsistent with the latest quarterly loss and needs verification.
• Micro-cap size of ₹5 crore means a small revival in operations could have outsized impact.

Concerns

• Sales collapsed by 93.09%, and latest quarter revenue is ₹0 crore, indicating near-total business shutdown.
• Latest quarterly net loss of ₹1 crore is material against a ₹5 crore market cap.
• ROCE is 0.00%, P/E is 0.00, and book value/debt-equity are unavailable, leaving no valuation or safety anchor.
• Price of ₹5.30 is below the 52-week range of ₹6.00-₹9.82, showing persistent selling pressure and no support.

AI Analysis

I have learned that a wonderful business at a fair price is better than a poor business at a cheap price. Integ. Thermopl. fails that test today. This is a plastic products company with sales down 93.09%, and the latest quarter shows sales of ₹0 crore and a net loss of ₹1 crore. Against a market capitalization of just ₹5 crore, that loss is enormous. The price of ₹5.30 is even below the 52-week range of ₹6.00 to ₹9.82; Mr. Market is not offering a bargain, he is offering a warning. Graham taught me to measure certainty through book value and earnings power. Here, book value and debt-equity are not available, ROCE is zero, and P/E is meaningless. The reported ROE of 6.39% conflicts with the latest quarterly loss, so I cannot trust the aggregate numbers. Profit growth of 61.89% is a mathematical illusion from a very low base; it does not represent a recoverable franchise. The Piotroski F-Score of 5/9 is middling, not enough to overcome the disappearance of revenue. There is no dividend, no promoter holding disclosure, and no evidence of a moat. In India’s market, micro-caps like this are often vehicles for value traps. Unless we see real orders, honest financials, and a credible path to positive earnings, this is a business I would watch from the sidelines. My job is to invest with margin of safety, not to guess at turnarounds. This is a speculative turnaround at best, and the data does not support action today.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer